Exponent Balance Sheet Health
Financial Health criteria checks 6/6
Exponent has a total shareholder equity of $356.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $646.8M and $290.7M respectively. Exponent's EBIT is $111.3M making its interest coverage ratio -15.6. It has cash and short-term investments of $187.2M.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | -15.6x |
Cash | US$187.15m |
Equity | US$356.09m |
Total liabilities | US$290.69m |
Total assets | US$646.78m |
Recent financial health updates
No updates
Recent updates
Exponent (NASDAQ:EXPO) Has Announced That It Will Be Increasing Its Dividend To $0.28
Feb 06Exponent, Inc. (NASDAQ:EXPO) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Feb 04Exponent, Inc.'s (NASDAQ:EXPO) Business Is Yet to Catch Up With Its Share Price
Jan 21A Look Into Exponent's (NASDAQ:EXPO) Impressive Returns On Capital
Nov 01Investors Should Be Encouraged By Exponent's (NASDAQ:EXPO) Returns On Capital
Jul 28Exponent (NASDAQ:EXPO) Will Pay A Larger Dividend Than Last Year At $0.26
May 02Why The 33% Return On Capital At Exponent (NASDAQ:EXPO) Should Have Your Attention
Apr 19Exponent (NASDAQ:EXPO) Has Announced That It Will Be Increasing Its Dividend To $0.26
Feb 21Exponent (NASDAQ:EXPO) Will Pay A Larger Dividend Than Last Year At $0.26
Feb 07Returns On Capital Are A Standout For Exponent (NASDAQ:EXPO)
Dec 26Do Exponent's (NASDAQ:EXPO) Earnings Warrant Your Attention?
Oct 12Under The Bonnet, Exponent's (NASDAQ:EXPO) Returns Look Impressive
Sep 24Exponent GAAP EPS of $0.49 beats by $0.04, revenue of $130.28M beats by $11.75M
Jul 28With EPS Growth And More, Exponent (NASDAQ:EXPO) Makes An Interesting Case
Jul 11Returns On Capital Are A Standout For Exponent (NASDAQ:EXPO)
Jun 23I Ran A Stock Scan For Earnings Growth And Exponent (NASDAQ:EXPO) Passed With Ease
Apr 10Shareholders Are Optimistic That Exponent (NASDAQ:EXPO) Will Multiply In Value
Mar 22Exponent's (NASDAQ:EXPO) Shareholders Will Receive A Bigger Dividend Than Last Year
Feb 08Are Exponent, Inc. (NASDAQ:EXPO) Investors Paying Above The Intrinsic Value?
Feb 05Here's Why I Think Exponent (NASDAQ:EXPO) Might Deserve Your Attention Today
Jan 02Capital Investment Trends At Exponent (NASDAQ:EXPO) Look Strong
Dec 15If You Like EPS Growth Then Check Out Exponent (NASDAQ:EXPO) Before It's Too Late
Sep 24Slowing Rates Of Return At Exponent (NASDAQ:EXPO) Leave Little Room For Excitement
Aug 06Financial Position Analysis
Short Term Liabilities: EXPO's short term assets ($379.5M) exceed its short term liabilities ($161.9M).
Long Term Liabilities: EXPO's short term assets ($379.5M) exceed its long term liabilities ($128.8M).
Debt to Equity History and Analysis
Debt Level: EXPO is debt free.
Reducing Debt: EXPO has no debt compared to 5 years ago when its debt to equity ratio was 0.09%.
Debt Coverage: EXPO has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: EXPO has no debt, therefore coverage of interest payments is not a concern.